At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 90 enrolled
Drug / intervention
Ketamine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Controlled Trial of Intranasal Sub-dissociative Dosing of Ketamine Compared to Intranasal Fentanyl for Treatment of Pain Associated With Acute Extremity Injuries in Children
Children's Hospital Medical Center, Cincinnati·interventional·Posted May 20, 2016·Updated Sep 1, 2020
In Brief
A Phase 3 clinical trial evaluating Ketamine and Fentanyl for Pain and Traumatic Limb Injury. Completed, enrolled 90 participants across 1 site.
Detailed Summary
This study compares the analgesic effect of intranasal sub-dissociative dosing of ketamine and intranasal fentanyl in children presenting to the Emergency Department with acute extremity injuries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Traumatic Limb Injury
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMar 2016
First PostedMay 2016
Primary CompletionFeb 2017
Study CompletionMar 2017
TodayJul 2026
First PostedMay 20, 2016
Enrollment StartMar 31, 2016
Primary CompletionFeb 22, 2017
Study CompletionMar 21, 2017
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.1 years ago
Interventions
Ketaminedrug
Fentanyldrug